70 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
4
Discovery of a sulfamate-based steroid sulfatase inhibitor with intrinsic selective estrogen receptor modulator properties.
Chu De Qu£Bec - Research Center (Chul, T4)
7
Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
Central University of Punjab
72
Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
Punjabi University
2
Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors.
University of Sharjah
45
Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
American University of Ras Al Khaimah
70
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
University of Bath
16
Synthesis of bicoumarin thiophosphate derivatives as steroid sulfatase inhibitors.
Gdansk University of Technology
16
A-ring substituted 17ß-arylsulfonamides of 17ß-aminoestra-1,3,5(10)-trien-3-ol as highly potent reversible inhibitors of steroid sulfatase.
University of Waterloo
10
Design and synthesis of silicon-containing steroid sulfatase inhibitors possessing pro-estrogen antagonistic character.
The University of Tokyo
1
Synthesis, structure-activity relationship of iodinated-4-aryloxymethyl-coumarins as potential anti-cancer and anti-mycobacterial agents.
P.C. Jabin Science College
3
Evaluation of sulfatase-directed quinone methide traps for proteomics.
Bielefeld University
21
Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
University of Bath
43
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template.
University of Bath
6
Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents.
University of Bath
13
2-(1-adamantyl)-4-(thio)chromenone-6-carboxylic acids: potent reversible inhibitors of human steroid sulfatase.
Novartis Institute For Biomedical Research Vienna
13
Estrone formate: a novel type of irreversible inhibitor of human steroid sulfatase.
Novartis Institutes For Biomedical Research Gdc
11
Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Novartis Research Institute Vienna
29
2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Novartis Research Institute Vienna
30
Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.
Laval University
2
Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
University of Bath
5
Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol.
Laval University
2
Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.
University of Bath
2
Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential.
University of Bath
17
Inhibition of estrone sulfatase (ES) by alkyl and cycloalkyl ester derivatives of 4-[(aminosulfonyl)oxy] benzoic acid.
Kingston University
2
2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agents.
University of Bath
7
The difluoromethylene group as a replacement for the labile oxygen in steroid sulfates: a new approach to steroid sulfatase inhibitors.
University of Waterloo
2
6-(2-adamantan-2-ylidene-hydroxybenzoxazole)-O-sulfamate: a potent non-steroidal irreversible inhibitor of human steroid sulfatase.
Novartis Forschungsinstitut
18
The mechanism of the irreversible inhibition of estrone sulfatase (ES) through the consideration of a range of methane- and amino-sulfonate-based compounds.
Kingston University
12
Inhibition of estrone sulfatase (ES) by derivatives of 4-[(aminosulfonyl)oxy] benzoic acid.
Kingston University
13
4,4'-Benzophenone-O,O'-disulfamate: a potent inhibitor of steroid sulfatase.
Novartis Research Institute Vienna
9
Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES).
Kingston University
34
A novel type of nonsteroidal estrone sulfatase inhibitors.
Hans-Kn�Ll Institute of Natural Products Research
15
Acid dissociation constant, a potential physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
Kingston University
5
Determination and use of a transition state for the enzyme estrone sulfatase (ES) from a proposed reaction mechanism.
Kingston University
13
Hydrophobicity, a physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
Kingston University
4
Derivation of a possible transition-state for the reaction catalysed by the enzyme estrone Sulfatase (ES).
Kingston University
15
17 alpha-alkyl- or 17 alpha-substituted benzyl-17 beta-estradiols: a new family of estrone-sulfatase inhibitors.
Laval University
1
Phosphonates and thiophosphonates as sulfate surrogates: synthesis of estrone 3-methylthiophosphonate, a potent inhibitor of estrone sulfatase
TBA
34
17ß-Arylsulfonamides of 17ß-aminoestra-1,3,5(10)-trien-3-ol as highly potent inhibitors of steroid sulfatase.
University of Waterloo
18
Inhibition of steroid sulfatase with 4-substituted estrone and estradiol derivatives.
University of Waterloo
14
Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory Activity
TBA
2
3,17-disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in vitro and in vivo anticancer activity.
University of Bath
38
Thiosemicarbazones of formyl benzoic acids as novel potent inhibitors of estrone sulfatase.
Institute For Natural Products Research and Infection Biology
6
Latest developments in coumarin-based anticancer agents: mechanism of action and structure-activity relationship studies.
Csir-Central Glass & Ceramic Research Institute
9
Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agents.
University of Sharjah
13
Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for
Saarland University
9
2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity.
University of Bath
7
Engagement of phytoestrogens in breast cancer suppression: Structural classification and mechanistic approach.
Central University of Punjab
27
Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist.
Shandong University
7
A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.
University of Bath
38
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis.
Saarland University
21
An overview on Estrogen receptors signaling and its ligands in breast cancer.
Zhejiang University
17
N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase.
Novartis Institutes For Biomedical Research
13
Nortropinyl-arylsulfonylureas as novel, reversible inhibitors of human steroid sulfatase.
Novartis Research Institute Vienna
6
Design and synthesis of dansyl-labeled inhibitors of steroid sulfatase for optical imaging.
Laval University
5
A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation.
University of Sharjah
11
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors.
University of Cagliari
27
Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.
University of Sharjah
59
Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
Indian Institute of Technology (Bhu)
2
Synthesis and sulfatase inhibitory activities of (E)- and (Z)-4-hydroxytamoxifen sulfamates.
Duquesne University
87
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design.
Bristol Myers Squibb
17
Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.
Gdansk University of Technology
14
First Dual Inhibitors of Steroid Sulfatase (STS) and 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Designed Multiple Ligands as Novel Potential Therapeutics for Estrogen-Dependent Diseases.
Saarland University
27
Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitors
Iteos Therapeutics
16
Discovery of SCH446211 (SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication.
Schering-Plough Research Institute
31
Novel 4-anilinoquinazolines with C-7 basic side chains: design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors.
AstraZeneca